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Abstract
Background: Lipopolysaccharides (LPS) are complex, amphipathic biomolecules that constitute the major surface
component of Gram-negative bacteria. Leptospira, unlike other human-pathogenic spirochetes, produce LPS,
which is fundamental to the taxonomy of the genus, involved in host-adaption and also the target of diagnostic
antibodies. Despite its significance, little is known of Leptospira LPS composition and carbohydrate structure among
different serovars.
Results: LPS from Leptospira interrogans serovar Copenhageni strain L1-130, a pathogenic species, and L. licerasiae
serovar Varillal strain VAR 010, an intermediately pathogenic species, were studied. LPS prepared from aqueous and
phenol phases were analyzed separately. L. interrogans serovar Copenhageni has additional sugars not found in
L. licerasiae serovar Varillal, including fucose (2.7 %), a high amount of GlcNAc (12.3 %), and two different types
of dideoxy HexNAc. SDS-PAGE indicated that L. interrogans serovar Copenhageni LPS had a far higher molecular
weight and complexity than that of L. licerasiae serovar Varillal. Chemical composition showed that L. interrogans
serovar Copenhageni LPS has an extended O-antigenic polysaccharide consisting of sugars, not present in L. licerasiae
serovar Varillal. Arabinose, xylose, mannose, galactose and L-glycero-D-mannoheptose were detected in both
the species. Fatty acid analysis by gas chromatography–mass spectrometry (GC-MS) showed the presence of
hydroxypalmitate (3-OH-C16:0) only in L. interrogans serovar Copenhageni. Negative staining electron microscopic
examination of LPS showed different filamentous morphologies in L. interrogans serovar Copenhageni vs.
L. licerasiae serovar Varillal.
Conclusions: This comparative biochemical analysis of pathogenic and intermediately pathogenic Leptospira LPS
reveals important carbohydrate and lipid differences that underlie future work in understanding the mechanisms
of host-adaptation, pathogenicity and vaccine development in leptospirosis.
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Background
Human leptospirosis is a common, globally-important
and neglected zoonotic infectious disease, caused by spi-
rochetes of the genus Leptospira [1], a disease of particu-
lar public health importance in tropical and subtropical
countries [2]. Chronically infected mammalian reservoir
hosts (e.g., rodents, cattle, dogs and swine) excrete the
organism in urine, contaminating water and soil the
principal vehicles for human infection. There are at
least 22 recognized species of Leptospira that have been
further classified into three major subgroups: Pathogenic,
Intermediately Pathogenic and Non-pathogenic (sapro-
phytes) [3], comprising ≥ 250 serotypes (“serovars”) based
primarily on the immunological characterization of
surface lipopolysaccharide (LPS) [4–6], a feature that
distinguishes Leptospira from other human-infecting
spirochetes, which do not produce LPS.
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LPSs are complex, amphipathic biomolecules that con-
stitute the major surface antigen of Gram-negative bac-
teria [7, 8]. LPS is composed of three covalently-linked
distinct components: lipid A, which is the hydrophobic
part embedded in the outer membrane; O-antigen or O-
polysaccharide, which is extended from the cell surface to
the external environment; and the core oligosaccharide,
which links the O-antigen to the lipid A. LPS with and
without O-antigen side chains are referred to as smooth
and rough LPS, respectively. Several Gram-negative or-
ganisms have been shown to produce heterogeneous (both
smooth and rough) LPS [9, 10]. Leptospira LPS plays an
essential role in pathogenesis colonization and dissemin-
ation of Leptospira in mouse models [11–13]. LPS is one
of the target antigen for diagnosis [14, 15] and also poten-
tial candidate for vaccine development [7, 16, 17].
In contrast to the pathogenic strain, L. interrogans sero-
var Copenhageni strain Fiocruz L1-130, the intermediately
pathogenic strain L. licerasiae serovar Varillal strain VAR
010 grows rapidly in vitro, but neither caused disease nor
was molecularly detectable in experimentally infected
hamsters or mice [18]. L. licerasiae serovar Varillal strain
VAR 010 (VAR010) causes mild disease in humans [18]
compared to L. interrogans serovar Copenhageni strain
Fiocruz L1-130 infection, which frequently result in life-
threatening illness characterized by jaundice, shock, kid-
ney injury and hemorrhage [19, 20]. These critical obser-
vations suggest that there are important biological and
virulence differences between pathogenic and intermedi-
ately pathogenic Leptospira species, which can be further
exploited by comparative analysis of key components to
understand the pathogenesis and host colonization.
LPS is considered as one of the central component of
the pathogenesis in Gram-negative organisms including
pathogenic Leptospira species [8, 12]. Therefore, com-
parative characterization of LPS of a pathogenic and
intermediately pathogenic Leptospira species is critical
to delineate sugar and fatty acid molecules essential for
the pathogenesis and colonization in the host.
Apart from its overall structural similarity to Gram-
negative LPS, relatively little is known about the com-
position and structure of Leptospira LPS [11, 12, 21].
Until now, the chemical composition and structure of
the LPS produced by an intermediate Leptospira have not
been studied. This is particularly important considering
the reduced complexity of the L. licerasiae serovar Varillal
rfb locus (a modest 6-gene-operon) compared to that of L.
interrogans Copenhageni, which contains 91 genes, des-
pite the fact that both serovars have a common reservoir
host: Rattus norvegicus [3]. Though this association is not
absolute, reservoir species are thought to maintain specific
serovars such as Copenhageni in rats and Canicola in
dogs. Indeed, despite differing genomic backgrounds, L.
interrogans subtype Harjoprajitno and L. borgpetersenii
serotype Hardjobovis are indistinguishable serologically
and share a common reservoir host [22] suggesting that
LPS plays an important role in determining host-
specificity.
To establish the biochemical basis for the structural
determination of the carbohydrate component of lepto-
spiral LPS, the biochemical composition of LPS of the
high-grade pathogenic L. interrogans serovar Copenha-
geni was compared to the LPS of the intermediately
pathogenic L. licerasiae Varillal LPS. Further, of biological
relevance given that pathogenic bacterial LPS may well be
associated with host adaptation, these two Leptospira
share Ratttus species as their mammalian reservoir host
[18]. Importantly, the rfb loci of these two Leptospira have
great differences in their complexity: L. interrogans
serovar Copenhageni has 95 rfb locus genes [23], while
L. licerasiae has 6 rfb locus genes [3]. This study is the
first to compare the biochemical composition of LPS
from pathogenic and intermediate Leptospira sharing a
common reservoir host and having varying pathogenic




This study was carried out in accordance with the rec-
ommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health
in AAALAC-approved facilities. The experimental animal
work was approved by the Institutional Animal Care and
Use Committee of the University of California San Diego
under protocol S03128H.
Strains and culture condition and LPS extraction
Leptospira interrogans serovar Copenhageni strain Fiocruz
L1-130, a pathogen, was maintained in-vitro, passaged
through hamsters, and re-isolated from infected hamster
liver; low-passage derivatives (P10 or less) were used for
all the experiments. The intermediate pathogen, L. licera-
siae serovar Varillal (VAR010) was originally isolated from
Rattus spp. in the Peruvian Amazon [18], adapted to in-
vitro culture conditions in our laboratory, and analyzed
at the whole genome level [3]. Both strains were
cultivated in Ellinghausen-McCullough-Johnson-Harris
(EMJH) medium (Becton Dickinson, Sparks, Maryland)
with slow rotary shaking (100 rpm) at 30 °C. Leptospira
cells were collected from mid-log cultures by centrifu-
gation at 14,000 rpm for 30 minutes, and then washed
three times with sterile PBS before LPS extraction.
Crude LPS was prepared by hot phenol-water extraction
as described previously [24], and extensively dialyzed
against Milli-Q water (8 changes for 4 days) to remove
phenol then lyophilized. Lyophilized crude material was
re-suspended in 10 mL of Mill-Q water, treated with
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DNase and RNase (Benzonase Nuclease, Sigma-Aldrich,
St. Louis, MO) followed by proteinase-K digestion
(Sigma-Aldrich, Product No. P6556). Purified LPS was
pelleted by ultracentrifugation (120,000 g for 4 h at 4 °C),
dissolved in Milli-Q water and lyophilized. Stock solutions
of 1 mg/mL of purified LPS were prepared from both
aqueous and phenol phases, and known amounts (by
weight) were used for SDS-PAGE and chemical compos-
ition analysis.
Chemical composition analysis of LPS extracted from
aqueous (AQ) and phenol (PH) phases
Neutral monosaccharides were identified by GC-MS as
their alditol acetate derivative (AA). Briefly, a known
amount of LPS was spiked with 2 μg of myo-inositol as in-
ternal standard, followed by hydrolysis with 2 N trifluor-
oacetic acid (TFA) at 100 °C for 4 h. Hydrolyzed samples
were cooled to room temperature, and a dry nitrogen
flush used to remove excess acid followed by repeated co-
evaporation of the reaction mixture with 100 μl of 50 %
aqueous isopropyl alcohol. The liberated monosaccharide
aldoses were further reduced to corresponding alditols by
sodium borohydride solution (1 mg/mL in 1 M ammo-
nium hydroxide) at room temperature overnight. Excess
sodium borohydride was neutralized using cold aqueous
30 % acetic acid (HOAc), followed by removal of boric
acid from the reaction mixture as volatile methyl borate
using a dry nitrogen flush. Finally, sugar alditols were
reacted with a 1:1 (v/v) mixture of pyridine and acetic an-
hydride at 100 °C for 1 h to form corresponding alditol
acetate derivatives. After removal of excess reagent by dry
a nitrogen flush, dried samples were extracted with di-
chloromethane and analyzed by GC-MS (Agilent Tech-
nologies 7820A GC system; 5975 Series MSD) using a
Restek-5 ms (Restek Cat No. 13423) capillary column.
Ultrapure helium was used as carrier gas at a linear
flow rate of 1.25 mL/min and a temperature gradient
(120 °C-10 °C for 1 min, 140 °C-2 °C for 1 min, 220 °C
for 2 min, 5 °C for 1 min and 230 °C for 4 min). The in-
jector temperature and transfer temperatures were
maintained at 220 °C and 280 °C respectively. The con-
stituent monosaccharides in LPS were identified and
quantified by comparing the retention time and mass
fragmentation pattern in electron impact (EI) positive
ion mode with standard sugars.
Fatty acid analysis of AQ and PH layers by GC-MS as fatty
acid methyl ester (FAME) and trimethyl silyl ether (Tri-Sil)-
FAME of hydroxyl fatty acids
Dried LPS samples (50 μg) from both aqueous and phe-
nol layers were treated with 200 μL 1 M methanolic HCl
prepared using a 3 N methanolic HCl kit (Supelco, Cat
No. 3–3355) for 16 h at 80 °C. The samples were placed
in an ice bath and slowly evaporated under a dry
nitrogen stream until almost half of the sample volume
had evaporated. To this reaction mixture, cold half-
saturated NaCl was added followed by the addition of
1 mL chloroform. The samples were vortexed at high
speed for 1 min with a 20-sec pulse, and then allowed to
settle for 1 min, and then centrifuged at 2000 rpm for
2 min (Beckman Coulter, Allegra 25R centrifuge) to sep-
arate organic and aqueous layers. The lower organic
layer was carefully removed to a glass hydrolyzing tube,
and the aqueous layer was extracted twice with 0.5 mL
of chloroform. Chloroform fractions were pooled then
washed with 2.0 mL of cold Milli-Q water twice, and the
organic layer was dried down. For detection of hydroxy
fatty acids, the dried fatty acid methyl esters were treated
with 100 μL of Tri-Sil HTP reagent (Thermo Scientific,
Cat No. TS-48999) at 80 °C for 30 min. The samples
were cooled in an ice bath and then dried using a dry
nitrogen stream, and then dissolved in hexane and ana-
lyzed by GC-MS.
FAME derivatized samples were analyzed by GC-MS
(Agilent Technologies 7820A GC system; 5975 Series
MSD) using a Restek-5 ms (Restek Cat No. 13423) ca-
pillary column. Ultrapure helium was used as a carrier
gas at a linear flow rate of 1.1971 mL/min and the fol-
lowing temperature gradient (100 °C-5 °C for 1 min,
120 °C for 1 min, 3 °C for 1 min and −230 °C for
4 min). The injector temperature and transfer line
temperature were maintained at 220 °C and 280 °C.
Fatty acids were identified by their characteristic EI
fragmentation pattern and corresponding retention
times and the percentage composition calculated from
the area under the respective peaks.
KDO (2-keto-3-deoxyoctonate) analysis
KDO was analyzed using reverse phase HPLC with a
C18 column after tagging with a fluorophore 4, 5
methylenedioxy-1, 2-phenylenediamine dihydrochlor-
ide (DMB) (Sigma, A89804). Briefly, 25 μg of LPS was
hydrolyzed using 100 μL of 2 M HOAc at 80 °C for 3 h
followed by removal of HOAc in a speed vac. The sam-
ple was then spin filtered using a 10 K (MW cut off )
spin filter (Nanosep 10 K Omega, PALL Life Sciences,
product No. OD010C34). The flow-through containing
free KDO was reacted with DMB reagent at 50 °C for
2.5 h; a known amount of DMB-KDO was injected into an
RP-HPLC equipped with an online fluorescence detector
(Dionex Ultimate 3000 UHPLC-Focused Plus). A Phe-
nomenex C18 reverse phase column (250 mm x 4.6 mm,
5 micron particle size) was used for HPLC analysis with
an isocratic solvent mixture of consisting of methanol
(8 %) and acetonitrile (5 %). For fluorescence detection,
the excitation and emission wavelengths were set to
373 nm and 448 nm respectively.
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Electron microscopy
A drop of LPS solution (1 mg/mL in water) was deposited
on a carbon coated mesh grid (200 lines/inch) and air-
dried. The sample containing mesh was negatively stained
with 2 % (w/v) uranyl acetate following a published
method [18]. The air-dried stained grid was examined
using a Joel 1200 Ex II TEM microscope at 80 kV available
at the core facility at UC San Diego (emcore.ucsd.edu).
Results
Electrophoretic mobilty of LPS extracted from AQ and PH
phases
The silver-stained electrophoretic profiles of LPS fractions
from L1-130 and VAR 10 were compared with that of an
E. coli control (Fig. 1). The migration pattern of Leptospira
LPS of both strains did not show the ladder-like pattern,
characteristic Gram-negative smooth (S) LPS. The electro-
phoretic mobility of VAR010 LPS found in AQ and PH
layers were similar, consisting of fast migrating low-MW
band. By contrast, the AQ and PH layers of L1-130 LPS
were distinct. L1-130 LPS isolated from the AQ layer dis-
played higher-MW to low-MW bands, forming a smear
like pattern.
GC-MS analysis of monosaccharides obtained from AQ
and PH phase LPS
The carbohydrate composition of LPS of serovars Copen-
hageni and Varillal are summarized in Fig. 2 and Table 1.
The monosaccharides present in both the strains are ara-
binose (Ara), rhamnose (Rha), xylose (Xyl), mannose
(Man) and galactose (Gal). Several other sugar moieties
are only present in the pathogen L. interrogans Copenha-
geni were detected, including fucose (Fuc, 2.7 %), N-
acetylglucosamine (GlcNAc, 12.3 % in Aq-LPS and 2.03 %
in Ph-LPS) and trace amounts of N-acetylgalactosamine
(GalNAc, 0.35 % in the AQ layer). Two other sugars were
present only in the AQ layer of serovar Copenhageni
(Fig. 2), epimers of 2-N-acetyl-2, 6-dideoxy hexosamine
(2,6-dideoxyHexNAc). The retention time suggests these
sugars could be either gluco- or galacto- configured
dideoxy HexNAc sugars, commonly known as N-acetyl
quinovosamine (QuiNAc) and N-acetyl fucosamine (Fuc-
NAc). Chemical composition analysis also demonstrated
the presence of O-methylated hexose residue in different
fractions of LPS of both strains.
Fatty acid composition analysis of LPS from intermediate
and pathogenic strain
The fatty acid composition of different LPS fractions from
L. interrogans serovar Copenhageni strain Fiocruz L1-130
and L. licerasiae serovar Varillal strain VAR010 (VAR010)
are summarized in Table 2 and their corresponding GC-
MS spectra are shown in Fig. 3. The LPSs consist of
hydroxyl-lauric acid (3-OH C12:0); palmitic acid (C16:0);
stearic acid (C18:0); oleic acid (C18: 1); myristic (C14:0)
acid; hydroxyl-myristic acid (3-OH C14:0), hydroxyl pal-
mitic acid (3-OH C16:0), and several other minor fatty
acids such as myristoleic acid (C14: 1) and palmitoleic acid
(C16: 1). Hydroxylauric (3-OH-C12:0) was present in
higher amounts in serovar Copenhageni LPS as compared
to that of Varillal, and hydroxypalmitate was only detected
in serovar Copenhageni.
Analysis of KDO
KDO in AQ and PH layer of L. interrogans serovar
Copenhageni strain Fiocruz L1-130 was estimated to be
3.6 and 4.7 pmole per 12.5 μg of LPS, respectively
(Fig. 4a, b). The KDO contents were strikingly low in L.
licerasiae serovar Varillal strain VAR010 in both phenol
and aqueous layer LPS samples (Fig. 4c and d).
Ultra-structure of Leptospiral LPS
Electron microscopic examination of negatively stained
LPS extracted from L. interrogans serovar Copenhageni
strain Fiocruz L1-130 and L. licerasiae serovar Varillal
strain VAR010 had different morphologies (Fig. 5).
VAR010 LPS is a closely packed sheet comprised of inter-
woven smaller thread-like filaments (Fig. 5a). By contrast,
Fig. 1 Comparative electrophoretic profile of lipopolysaccharide
(LPS) extracted from pathogenic and intermediately pathogenic
Leptospira strains. LPS was extracted from the pathogenic species,
Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130,
and from the intermediately pathogenic species, Leptospira licerasiae
serovar Varillal strain VAR010. LPS was isolated from both aqueous
(AQ) and phenol (PH) layers of both species; profiles were determined
by running 20 μl of LPS samples in SDS-PAGE followed by a periodic
acid-silver staining method to detect LPS. Escherichia coli 055: B5
(E. coli) LPS was used as a standard LPS, and protein ladder (M)
was used to localize the approximate the size of the LPS band
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L1-130 LPS consisted of filaments are larger in size, clus-
tered together that did not form any definite sheet like
structure (Fig. 5b).
Discussion
Here we report key experimentally-determined biochem-
ical details of the composition of the lipopolysaccharide
(LPS) of L. licerasiae serovar Varillal, an intermediate
pathogen leptospire with unique antigenicity [18], broad
reactivity among people resident in the Peruvian Amazon
[18], and an unusually small rfb locus comprised of only 6
genes [3]. This analysis of L. licerasiae serovar Varillal LPS
demonstrated important differences when compared to
the LPS of the highly pathogenic L. interrogans serovar
Copenhageni. We found that L. licerasiae Varillal and L.
interrogans Copenhageni LPS differ significantly in carbo-
hydrate and fatty-acid compositions, particularly in that L.
interrogans serovar Copenhageni was found to contain
fucose, N-acetylglucosamine and N-acetylgalactosamine,
FucNAc and QuicNAc and hydroxypalmitate (3-OH-
C16:0) while L. licerasiae serovar Varillal did not.
While leptospiral LPS does not have potent endotoxi-
genic properties [25], it has long been known to be the
antigen that defines serovar and serogroups, and anti-
leptospiral LPS antibodies are responsible for serovar-
specific immunity [26–36]. Leptospira LPS plays a major
role in immunity [37, 38], potential candidate for vaccine
development [17] and also anti-LPS monoclonal anti-
bodies used for diagnosis [14, 17]. In contrast, the other
human-infecting spirochetes—Borrelia spp. and Trepo-
nema spp.—do not have LPS or an outer membrane
[12], so that these biochemical components and struc-
tures do not play a role in the biology of these patho-
gens. Transposon mutants, deficient in LPS production,
demonstrated that LPS is a critical virulence determinant
and is necessary for colonization of the vertebrate host
[12, 37], similar to that of Salmonella spp. LPS [39].
However, detailed analysis of leptospiral LPS remains
understudied, and the present report provides a new ap-
proach to such studies.
In our observations, purification of LPS from Leptospira
species differed from other Gram-negative organisms, in
which LPS precipitation primarily occurs from the
aqueous phase of hot phenol-water extracts. In earlier
studies, aqueous phase Leptospira LPS were used for
composition analysis, immunological and biological
studies [18, 26–28]. However, a substantial amount of
Leptospira LPS also separates into the phenol layer
Fig. 2 Carbohydrate composition analysis of LPS of pathogenic and intermediate pathogenic Leptospira strains. LPS extracted from the pathogenic
species, Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130, and from the intermediately pathogenic species, Leptospira licerasiae serovar
Varillal strain VAR010, was subjected to gas chromatography–mass spectrometry (GC-MS) chromatography of monosaccharides as alditol acetate
derivatives: (a) Copenhageni aqueous layer LPS; (b) Copenhageni phenol layer LPS; (c) VAR010 aqueous layer LPS; (d) VAR010 phenol layer LPS.
Rha = 6-deoxymannopyranose; Fuc = 6-deoxygalactopyranose; Ara = arabinose; Xyl = xylose; Ino =Myo-inositol (internal standard); Man =mannose;
Glc = glucose; Gal = galactose; GlcNAc = 2-N-acetylglucosamine; L-D-Heptose = L-glycero-D-mannoheptose
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during LPS extraction procedures like Gram-negative
bacteria that contain smooth LPS [9]. Our results indi-
cate that Leptospira LPS is distributed differently in
phenol and aqueous layer in pathogenic (L1-130) and
intermediate pathogenic strain (VAR010). The distribu-
tion of LPS in organic and aqueous layers mainly de-
pends on the ratio of hydrophilic saccharide portion
and hydrophobic lipid part of the LPS [40, 41]. We ana-
lyzed LPS isolated from both aqueous and phenol layers
separately to compare chemical composition of serovars
Copenhageni and Varillal. The growth temperature of
an organism may also influence the LPS composition
and solubility. For example, in Yersinia pestis the LPS
compositions changes under two different growth
conditions (mammalian, 37 °C and environmental 25 °
C) mimicking host body temperatures [42] and simi-
larly evident in other pathogens [43, 44]. O-antigen
content of L. interrogans has been observed to change
between acute and chronic infection, and when culti-
vated under in vitro conditions [13]. Interestingly,
transmission of leptospirosis requires that Leptospira
survive and adapt to a wide variety of conditions (renal
tubules, urine, river, mud, soil, etc.) and characteristics
of these adaptations are not clear [13]. We cultured
both Leptospira species (L1-130 and VAR010) at 30 °C
in a medium rich in long chain fatty acids (EMJH
medium), a standard method. A potential and import-
ant limitation of the present study is that only the LPS
Table 1 Cabohydrate composition analysis of LPS of pathogenic versus intermediate pathogenic Leptospira strains
Sugar Pathogenic L1-130 Intermediate pathogenic VAR010
AQ LPS PH LPS Ave (SD) AQ LPS PH LPS Ave (SD)
Arabinose (Ara) 20.45 20.56 20.5 (0.05) 39.32 33.52 36.4 (5.8)
Rhamnose (Rha) 20.56 15.03 17.8 (2.8) 16.08 10.84 13.5 (2.6)
Fucose (Fuc) 2.17 0 (ND) 1.1 (1.1) 0 (ND) 0 (ND) 0 (ND)
Xylose (Xyl) 19.88 23.27 21.8 (1.7) 18.99 21.06 20.0 (1.0)
Mannose (Man) 8.74 12.73 10.7 (2.0) 15.56 19.91 17.7 (2.2)
Galactose (Gal) 14.66 16.65 15.7 (1.0) 7.87 13.2 10.5 (2.7)
Glucose (Glc) 0.89 2.29 1.59 (0.7) 2.18 1.48 1.6 (0.7)
N-acetylglucos- amine (GlcNAc) 12.3 2.03 7.2 (5.1) 0 (ND) 0 (ND) 0 (ND)
N-acetylgalacto-samine (GalNAc) 0.35 0 (ND) 0.18 (0.18) 0 (ND) 0 (ND) 0 (ND)
2-N-acetyl-2,6-dideoxy galactose (FucNAc) + (*) 0 (ND) + (*) 0 (ND) 0 (ND) 0 (ND)
2-N-acetyl-2,6-dideoxy Glucose (QuiNAc) + (*) 0 (ND) + (*) 0 (ND) 0 (ND) 0 (ND)
L-glycero-D-manno Heptose (L-D-Hep) 3.0 4.31 3.65 (0.7) 0 (ND) 4.03 2.0 (2.0)
LPS from Leptospira interogans serovar Copenhageni strain L1-130 (L1-130) and intermediate pathogenic, Leptospira licerasiae serovar Varillal strain VAR010 (VAR010)
were purified from both aqueous (AQ) and phenol layer (PH) and subjected for composition analysis separately. The sugar composition values of aqueous, phenol and
combined mean values (± SE) are presented as mole percentage of monosaccharides obtained in fractions. ND= not detected; FucNAc = 2-Nacetyl-2, 6-dideoxy
Galactose and QuiNAc = 2-Nacetyl-2, 6-dideoxy Glucose (*). FucNAc and QicNAc are proposed according to the EI mass fragmentation pattern and relative retention
times; however quantification could not be done due to unavailability of authentic standards for both monosaccharides
Table 2 Percentage of fatty acid composition analysis of LPS of pathogenic versus intermediate pathogenic Leptospira strains
Fatty acid Pathogenic L1-130 Intermediate pathogenic VAR010
AQ LPS PH LPS Ave (± SD) AQ LPS PH LPS Ave (±SD)
Myristoleic (C14:1) 0.0 1.32 0.66 (1.98) 0.71 1.37 1.04 (0.33)
Myristic acid (C14:0) 0.19 0.60 0.395 (0.205) 0.11 0.38 0.245 (0.135)
Hydroxylauric (3-OH-C12:0) 40.02 36.12 38.07 (1.95) 8.24 11.88 10.06 (1.82)
Palmitoleic (C16:1) 2.32 3.45 2.89 (0.565) 0.0 1.48 0.74 (0.74)
Palmitic (C16:0) 28.67 24.39 26.53 (2.14) 71.34 51.80 61.57 (9.77)
3-Hydroxymyristate (3-OH-C14:0) 0.97 0.94 0.955 (0.015) 3.55 4.28 3.915 (0.365)
Margaric acid (C17:0) 0.0 0.46 0.23 (0.23) 0 0.24 0.12 (0.12)
Oleic (C18:1) 11.78 19.19 15.49 (3.705) 1.37 16.27 8.82 (7.45)
Steric (C18:0) 2.57 2.40 2.49 (0.085) 14.47 12.28 13.375 (1.095)
3-hydroxypalmitate (3-OH-C16:0) 13.48 11.14 12.31 (1.17) 0.0 0.0 0.0
LPS from Leptospira interogans serovar Copenhageni strain L1-130 (L1-130) and intermediate pathogenic, Leptospira licerasiae serovar Varillal strain VAR010
(VAR010) were purified from both aqueous (AQ) and phenol layer (PH) and subjected for composition analysis separately. Fatty acids in both aqueous (AQ) and
phenol (PH) layer LPS extracts were measured and given in the table. Average (Ave) and Standard deviation (± SD) values are also presented in this table
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Fig. 3 Fatty acid composition analysis of lipopolysaccharide (LPS) from pathogenic and intermediately pathogenic Leptospira species. LPS was
extracted from the pathogenic species Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130 and the intermediately pathogenic species
Leptospira licerasiae serovar Varillal strain VAR010. LPS fractions were analyzed by gas chromatography–mass spectrometry (GC-MS) as fatty acid methyl
ester (FAME) and trimethyl silyl ether-FAME derivatives of hydroxyl fatty acids: (a) Copenhageni aqueous layer LPS; (b) VAR010 aqueous layer
LPS; (c) Copenhageni phenol layer LPS; (d) VAR010 phenol layer LPS
Fig. 4 Detection and quantitative estimation of 2-keto-3-deoxyoctonate (KDO) in pathogenic and intermediately pathogenic Leptospira species.
LPS extracted from the pathogenic species Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130, and the intermediately pathogenic
species Leptospira licerasiae serovar Varillal strain VAR010 was subjected to KDO analysis using reverse phase HPLC with a C18 column after
tagging with a fluorophore 4, 5 methylenedioxy-1, 2-phenylenediamine dihydrochloride (DMB). a Copenhageni aqueous layer LPS; (b) VAR010
aqueous layer LPS; (c) Copenhageni phenol layer LPS; (d) VAR010 phenol layer LPS
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of in vitro cultivated bacteria were studied. We ob-
tained sufficient amount of LPS from the in-vitro cul-
tured Leptospira strains (L1-130 and VAR010) for
chemical analysis, which is currently not feasible from
in vivo growing Leptospira.
Analysis of LPS by SDS-PAGE followed by periodic
acid-silver staining has been used to characterize LPS
heterogeneity in different Leptospira serovars [27] and
other Gram-negative bacteria [9, 33, 34]. The periodic-
silver stain gel (Fig. 1) shows that in the L1-130, the
fastest migrating LPS component is probably the lipid-
A core, and the slower migrating components are O-
antigens as seen in other Gram-negative organisms. In
VAR010 LPS are very compact (ranges up to 25 kDa) in
both aqueous/phenol layers LPS extraction. E. coli LPS
is characterized by a close succession of regularly
spaced bands representing increasing number of O-
antigen units. However, in L1-130 the O-side chain pat-
terns may be irregular resulting in a smear-like pattern.
The results make evident that the intermediate strain
appears to possess the rough type of LPS compared to
pathogenic strain that has both smooth and rough
form, and further suggests that the O-antigen carbohy-
drates in Leptospira are not simple repeating units. This
finding is particularly important as the O-antigen changes
have been previously observed in the same pathogenic
strain in acute versus chronic L. interrogans infection
animal model [13] and serial passaging in immuno-
incompetent hosts in other organisms [36]. Because of the
current lack of a small animal model for L. licerasiae (or
other intermediately pathogenic Leptospira), the VAR010
strain was maintained by in-vitro culture, which possibly
could have led to some sort of change in LPS molecule.
However, anti-VAR010 antisera continue to agglutinate
the in vitro passaged strain suggesting that the essential
antigen determinants are preserved. Our recent data
showed that we could infect Rattus norvegicus with
VAR010 to infect and establish chronic renal infection
(unpublished data, Carla Fernandez, Michael M. Matthias
and Joseph M. Vinetz, 2015).
We demonstrated that the sugar composition of LPS
of L1-130 and VAR010 differs, and that the LPS puri-
fied from aqueous and phenol layers of these Leptospira
is different. Interestingly, fucose, N-acetylglucosamine
and N-acetylgalactosamine are only found in L1-130
and not detected in the VAR010 LPS samples. FucNAc
and QuicNAc are only found in the aqueous layer LPS
from L1-130, and both the sugars are reported to be
present on the O-antigen repeat unit of semi-rough or
smooth type LPS in different pathogenic bacterial spe-
cies such as Vibrio cholera and Pseudomonas [45, 46].
Earlier publications show that there are high content of
rhamnose and arabinose in the LPS of pathogenic Leptos-
pira species, L. interrogans serovar Copenhageni and
L.interrogans serovar Hardjo [21, 47]. However, we ob-
served in the intermediate-pathogenic Leptospira species,
VAR010, arabinose amount was two-fold higher compared
to rhamnose. Therefore, we hypothesize that arabinose
could play a protective role in survival under certain envir-
onmental conditions. Azospirillums showed that a high
arabinose content in exopolysaccharide (EPS) plays an im-
portant role in cell aggregation that allows survival in a
hostile environment [48, 49].
In Gram-negative organisms lipid A is responsible for
the endotixic activity [8]. The lipid A of L. interrogans
has been reported to be structurally different from other
enterobacterial lipid A [25], and to be recognized by the
mouse innate immune system by TLR-2 and not TLR-4
[50]. The lipid A center is an essential component for
the viability of most bacteria, with a few exceptions. For
Fig. 5 Electron micrograph of lipopolysaccharide extracted from
pathogenic and intermediate pathogenic Leptospira strains. LPS were
spotted on a carbon-coated mesh, air-dried, negatively stained with
2 % uranyl acetate and examined under a transmission electron
microscope. The pictures show the different LPS structures of
intermediately pathogenic (L. licerasiae serovar Varillal strain VAR010,
top figure a scale bar 0.5 μM.) and pathogenic (L interogans serovar
Copenhageni strain Fiocruz L-130, bottom figure b scale bar 0.2)
strains, respectively
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example, Neisseria meningitidis can survive without lipid
A in the presence of capsular polysaccharide [51, 52].
The biological activity of LPS is dependent on several
structural features of the lipid A. Among them, the pres-
ence of phosphate group, substitution of the phosphate
residues (with phosphoethanolamine, phosphocholine and
methyl groups), alteration of fatty acyl residues, fatty acid
type and chain length [53].
The fatty acid moieties present in the lipid A consist
of chain lengths between C10-C14 in majority of organ-
isms and few organisms show C16-C18 [8]. For exam-
ples, P. aeruginosa expresses fatty acid of shorter chain
length C10 and C12; H. pylori possess longer chain of
fatty acids (C16-C18) and H. influenzae present C14
fatty acids [54]. In Enterobacteriaceae LPS, 3-OH-C14:0
is the dominant 3-OH-fatty acids [55]. The LPS of E. coli
contains fatty acids with chain length of C12 and 3-OH
C14:0 [8]. We analyzed the fatty acid from E. coli 011:B4
(Sigma, # L 2630, Data not shown here) indicated the
presence of 3-OH C14:0 as the major component. The
LPS of VAR010 shows the presence of 3-OH C14:0,
however it’s percentage is lot less in pathogenic strains.
Interestingly, 3-OH fatty acids C16:0 is only present in
L1-130 and not detected in VAR010. In Gram-negative
organisms, 3-Hydroxy long-chain fatty acids are essential
to the endotoxin activity and also used as a chemical
markers of LPS [56], hence the role of 3-OH C16:0 in
L1-130 need further evaluations. Hydroxylauric acid
present in both VAR010 and L1-130 in different ratio,
these finding was reported previously for L1-130 [25].
The fatty acid composition differed between the patho-
genic (L1-130) and intermediate pathogenic Leptospira
(VAR010) that we studied here; for example, fatty acid
hydroxypalmitate (3-OH-C16:0) was unique to the patho-
genic strain. The Leptospira have a unique metabolism
that requires a fatty acid-enriched medium [57, 58], and in
the host infectious Leptospira colonize kidney as a key
component of their life cycle [59]. These organs offer a
large amount of lipid supply to meet the essential fatty
acids requirements for spirochetes growth and multiplica-
tion [60]. The fatty acid metabolic pathway of unique fatty
acids of pathogenic Leptospira LPS can be a good target
for the intervention to prevent disease progression. Fatty
acid composition has previously been suggested to be re-
lated to pathogenicity, and this feature merits for further
investigation [61].
We carried out extensive processing to remove the
nucleic acids and protein contaminant from the LPS
preparation by nucleases treatment, proteolytic diges-
tion, ultracentrifugation and dialysis as per published
method of Leptospira LPS purification [24]. However, it
is possible that glycoproteins that are tightly complexed
with LPS and not amenable to protease digestion may
contribute to the lipid content. We acknowledge this as
a potential limitation of the LPS preparation by available
method. The percentages of fatty acids commonly found
in both strains such as palmitic acid, stearic and oleic
acid are contributions from some non-LPS components
such as glycolipoproteins that are co-extracted with the
LPS and could not be removed.
KDO (2-keto-3-deoxymanno-octulosonic acid) is an
eight carbon acidic sugar found in the LPS of Gram-
negative bacteria and it connects the Lipid A part to the
O-antigen. The conflicting ability to detect KDO and de-
tection of KDO in some pathogenic strains [11, 18, 26]
[24] makes it interesting to understand how sugars
might play a substitute role in the absence or limited
amount of KDO. We also found KDO in the phenol
phase extract of both virulent and intermediate strain
and the aqueous phase of the virulent strain only. The
amount of KDO in the intermediate was very low with a
small peak eluted at the same retention time corre-
sponding to standard KDO and L1-130 KDO peak. It is
possible that in the intermediately pathogenic strain
other sugars or other form of KDO might also be play-
ing a role in maintaining the weak linkage between O-
antigenic carbohydrate and the lipid-A part of LPS. For
example, KDO is replaced by 2-keto-D-glycero-D-talo-
octonic (KO) in Burkholderia cepacia, a Gram-negative
bacterial pathogens that causes respiratory infection in
cystic fibrosis patients [8].
Conclusions
This study is the first detailed biochemical composition
analysis of an intermediately pathogenic Leptospira LPS,
and the first to compare leptospiral LPS in Leptospira
pathogen vs. intermediate species. Many sugars and fatty
acid were found in L. interrogans Copenhageni L1-130 but
not in the intermediately pathogenic L. licerasiae Varillal
VAR010, which merits further investigation. Current and
forthcoming comparative whole Leptospira genomic ana-
lysis will allow for detailed genetic/genomic, functional
and structural analysis of leptospiral LPS, a molecule es-
sential to diverse aspects of this spirochete’s biology,
which will improve our understand of mechanisms of
pathogenesis and potential vaccine-related interventions.
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